Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Cancer crawled date : 2021 - 10 - 21 save search
Atossa Therapeutics CEO Dr. Steven Quay Emphasizes Importance of Breast Cancer Screening During Breast Cancer Awareness Month
Published: 2021-10-21 (Crawled : 14:15) - globenewswire.com
ATOS | $1.35 -12.34% -13.65% 3.9M
|
Health Technology
|
| O: -0.34%
H: 2.64%
C: -2.41%
cancer ceo breast cancer
Philips brings clarity to every moment of cancer care with new patient-centered innovations at ASTRO 2021
Published: 2021-10-21 (Crawled : 13:15) - globenewswire.com
PHG | News | $20.15 -0.89% -0.6% 740K
|
Health Technology
|
| O: 1.05%
H: 1.17%
C: 0.76%
cancer
First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis
Published: 2021-10-21 (Crawled : 12:00) - globenewswire.com
FWBI | News | $2.9 -3.97% -1.34% 50K
|
Manufacturing
|
| O: 3.73%
H: 1.96%
C: -3.27%
phase 2 biopharma cancer trial phase 2b
PDS Biotech Provides Update on National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationTemporary administrative suspension of recruitment
Published: 2021-10-21 (Crawled : 12:00) - biospace.com/
PDSB | $2.72 -2.86% -3.32% 610K
|
Health Technology
|
| O: -3.24%
H: 3.52%
C: -0.69%
phase 2 cancer biotech iot trial
BeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined with Nivolumab + Ipilimumab in Patients in 3rd Line Recurrent Small-Cell Lung Cancer Patients Who Failed Checkpoint Inhibitors
Published: 2021-10-21 (Crawled : 11:00) - beyondspringpharma.com
BYSI | $1.85 2.78% 3.23% 100K
|
Health Technology
|
| O: 0.0%
H: 0.6%
C: -2.27%
phase 2 lung cancer cancer plinabulin nivolumab
Gainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 56.82% 220M
|
Health Technology
SINT | $0.0373 62.88% 37.26% 460M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
EDBL | News | $6.66 46.37% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 600K
|
Manufacturing
TCON | $2.29 33.92% 26.61% 1.8M
|
Health Technology
TIRX | $0.4848 7.49% 24.58% 5.9M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
KZIA | $0.3442 18.28% 23.42% 290K
|
Health Technology
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.